Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.850
-0.070 (-1.79%)
At close: Sep 4, 2026, 4:00 PM EDT
3.800
-0.050 (-1.30%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Sana Biotechnology Employees
Sana Biotechnology had 142 employees as of December 31, 2025. The number of employees decreased by 52 or -26.80% compared to the previous year.
Employees
142
Change (1Y)
-52
Growth (1Y)
-26.80%
Revenue / Employee
n/a
Profits / Employee
-$1,491,704
Market Cap
1.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 142 | -52 | -26.80% | 142 | 0 |
| Dec 31, 2024 | 194 | -134 | -40.85% | 194 | 0 |
| Dec 31, 2023 | 328 | -93 | -22.09% | 328 | 0 |
| Dec 31, 2022 | 421 | 35 | 9.07% | 418 | 3 |
| Dec 31, 2021 | 386 | 121 | 45.66% | 383 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Monte Rosa Therapeutics | 173 |
| MoonLake Immunotherapeutics | 130 |
| Solid Biosciences | 121 |
| Janux Therapeutics | 113 |
| Inventiva | 77 |
| Jade Biosciences | 55 |
| Corvus Pharmaceuticals | 37 |
SANA News
- 4 days ago - Sana Biotechnology to Present at September 2026 Investor Conferences - GlobeNewsWire
- 20 days ago - Sana Biotechnology price target lowered to $6 from $7 at BofA - TheFly
- 26 days ago - Sana Biotechnology reports Q2 EPS (13c), consensus (12c) - TheFly
- 26 days ago - Sana Biotechnology Earnings release: Q2 2026 - Filings
- 26 days ago - Sana Biotechnology Quarterly report: Q2 2026 - Filings
- 26 days ago - Sana Biotechnology Slides: Corporate presentation - Filings
- 5 weeks ago - Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 7 weeks ago - Sana Biotechnology announces publication of long-term diabetes data - TheFly